Cardiff Oncology Stock (NASDAQ: CRDF) stock price, news, charts, stock research, profile.
You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.
Other companies in Cardiff Oncology’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Invizyne Technologies (NASDAQ:IZTC), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Adverum Biotechnologies (NASDAQ:ADVM).
Cardiff Oncology has a consensus price target of $8.50.
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $2.46 last updated November 22, 2024 at 7:55 PM EST.
There are no upcoming dividends for Cardiff Oncology.
Cardiff Oncology’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Cardiff Oncology.
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.